Cardio Diagnostics Holdings Inc

CDIO10 Dec 2024
Healthcare
$0.56
+0.27 (+27.27%)
Lowest Today
$0.55
Highest Today
$0.76
Today’s Open
$0.56
Prev. Close
$0.55
52 Week High
$3.56
52 Week Low
$0.19
BUY
SELL
To Invest in Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc

Healthcare
CDIO10 Dec 2024
₹
+0.27 (+27.27%)
1M
3M
6M
1Y
5Y
Low
$0.55
Day’s Range
High
$0.76
0.55
52 Week Low
$0.19
52-Week Range
52 Week High
$3.56
0.19
1 Day
-
1 Week
+80.84%
1 month return
+39.82%
3 month return
+81.86%
6 month return
-9.06%
1 Year return
-59.58%
3 Years return
-
5 Years return
-
10 Years return
-
Institutional Holdings
BlackRock Inc
2.64
Vanguard Group Inc
0.57
Vanguard Institutional Extnd Mkt Idx Tr
0.57
Geode Capital Management, LLC
0.46
Fidelity Extended Market Index
0.29
Northern Trust Corp
0.12
State Street Corp
0.11

Market Status

Fundamentals
Market Cap
22.24 mln
PB Ratio
6.03
PE Ratio
0
Enterprise Value
20.98 mln
Total Assets
4.46 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Organisation
Cardio Diagnostics Holdings Inc
Employees
7
Industry
Biotechnology
CEO
Dr. Meeshanthini V. Dogan Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Get expert assistance for portfolio management

BUY
SELL
Click here to see your activities